Peptide record

TPDB07645

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07645
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept AVPpred-BWR APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 14-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
INWLKLGKKMMSAL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C75H129N19O17S2
RDCEQHFPTYV
LK
1633.09
10.84
3
0
8
+3
-0.20
0.300
118.57
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
3.37
2
Residue Composition
number
1
A
0
R
1
N
0
D
0
C
0
E
0
Q
1
G
0
H
1
I
3
L
3
K
2
M
0
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 3 K: 3 M: 2 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
14 reviewed residue count
C75H129N19O17S2 sequence-only estimate (linear, free termini)
1633.09 sequence-only estimate (linear, free termini)
10.84 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.20 sequence-only estimate (linear, free termini)
0.300 sequence-only estimate (linear, free termini)
Evidence Records 18 records
Evidence 1 Activity

Activity

MIC
Antibacterial
65 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. su
Evidence 2 Activity

Activity

MIC
Antibacterial
9 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (
Evidence 3 Activity

Activity

MIC
Antibacterial
50-150 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

ilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (MIC 50-150 uM). The lower the CFU, the lower the MIC.
Evidence 4 Activity

Activity

MIC
Antifungal
65 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. su
Evidence 5 Activity

Activity

MIC
Antifungal
9 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP Antifungipept

Other

Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (
Evidence 6 Activity

Activity

MIC
Antifungal
50-150 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP Antifungipept

Other

ilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (MIC 50-150 uM). The lower the CFU, the lower the MIC.
Evidence 7 Activity

Activity

MIC
Antiparasitic
65 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. su
Evidence 8 Activity

Activity

MIC
Antiparasitic
9 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (
Evidence 9 Activity

Activity

MIC
Antiparasitic
50-150 µM

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

ilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (MIC 50-150 uM). The lower the CFU, the lower the MIC.
Evidence 10 Activity

Activity

MIC
Antiviral
65 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. su
Evidence 11 Activity

Activity

MIC
Antiviral
9 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

Active against E. coli (MIC 65 uM) and B. subtilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (
Evidence 12 Activity

Activity

MIC
Antiviral
50-150 µM

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

ilis (MIC 9 uM). Also active against S. aureus (more potent than against B. subtilis) and P. aeruginosa (MIC 50-150 uM). The lower the CFU, the lower the MIC.
Evidence 13 Activity

Activity

IC50
Hemolysis
100 µM
[Ref.18375018]IC50=100 µM against rat red blood cells

Target

rat red blood cells

Source & Reference

Hemolytik APD_complete PD_Hemolysis
DRAMP4
Peptides. 2008 Jun 29(6):992-1003.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
50% Hemolysis | 100 | µM | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs | Peptides | 2008
Evidence 15 Activity

Activity

50% Hemolysis
Toxicity
13 µM
Hemolytic Cytotoxic
50% Hemolysis | 13 | µM | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs | Peptides | 2008
Evidence 16 Activity

Activity

50% Hemolysis
Toxicity
>>100 µM
Hemolytic Cytotoxic
50% Hemolysis | >>100 | µM | target cell: Rat erythrocytes

Target

Rat erythrocytes

Source & Reference

NA
DBAASP
New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs | Peptides | 2008
Evidence 17 Activity

Activity

IC50
Toxicity
100 µM
Hemolytic
Hemolytic_activity: [Ref.18375018]IC50=100 µM against rat red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2008 Jun 29(6):992-1003.
Evidence 18 Hemolysis

Activity

100 µM
IC50
[Ref.18375018]IC50=100 µM against rat red blood cells
Hemolysis

Target

rat red blood cells

Source & Reference

APD_complete HemoPI PD_Hemolysis
Peptides. 2008 Jun 29(6):992-1003.
DRAMP4
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.